You are here
ACETAMINOPHEN TOXICITY DIAGNOSTICS, LLC
UEI: M7PNUQVP4RE3
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
100 Additional fresh samples for verification of assay to replace the original proposed banked samples that cannot be used due to repeated exposure to freezing and thawing.
Amount: $2,391,840.00James, Laura P Project Summary/Abstract The original plan for development of AcetaSTAT was to use banked samples of serum collected from acetaminophen overdose patients to verify the effectiveness of ...
SBIRPhase II2022Department of Health and Human Services National Institutes of Health -
AcetaSTAT Rapid Assay for Acetaminophen Liver Injury
Amount: $2,649,372.00DESCRIPTIONprovided by applicantAlthough acetaminophen is the most common drug for treating pain and feverand also the most common cause of life threatening drug induced liver damagethere are no tests ...
STTRPhase II2016Department of Health and Human Services National Institutes of Health -
Adduct Dipstick for Diagnosis of Acetaminophen Toxicity
Amount: $1,692,374.00DESCRIPTION (provided by applicant): Acetaminophen (APAP) is the most commonly used drug for the treatment of pain and fever in the world today. In large doses, APAP causes acute liver failure and is ...
STTRPhase II2011Department of Health and Human Services National Institutes of Health -
Dipstick Assay for Detection of Acetaminophen Protein Adducts
Amount: $399,546.00DESCRIPTION (provided by applicant): The ultimate goal of this STTR proposal is to develop a rapid, sensitive, and specific diagnostic test that can identify acetaminophen (APAP) protein adducts in hu ...
STTRPhase I2008Department of Health and Human Services National Institutes of Health
